Stay updated with breaking news from Tim Lu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company's planned...
- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, and Asia-based global healthcare investors Tybourne Capital Management
Senti Bio Adds Prominent Scientific and Industry Leaders to its Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace
The Microbiome Gains Momentum in Cancer Immunotherapy The Microbiome Gains Momentum in Cancer Immunotherapy Vedanta Biosciences develops drugs made from defined bacterial consortia. One of these drugs, a cancer drug called VE800, addresses a challenge that may commonly occur with microbiome-engaging cancer immunotherapeutics. The problem is variability in microbiome signatures. Vedanta’s CEO, Bernat Olle, PhD, says that with cancer, there is no “night and day type of signature” like that seen with Clostridium difficile infections. Olle suggests that overcoming this problem will require...
Meet Nargiz Ali Zada, an international student earning her MaineMBA. Find out what drew Nargiz to UMaine from Azerbaijan and why earning an MBA is important to her. Tell us a little bit about where you are from… I am from Baku, the capital city of Azerbaijan. Baku is an ancient, beautiful city on the coast of the Caspian Sea. It’s an important center for oil production. There are many historical monuments such as Gobustan, one of the oldest human settlements with more than 6,000 ancient rock carvings bearing testimony to 40,000 years of rock art. There’s also Atashgah Zoroastrian Fire ...